cancer-patients / English

add

Chest wall radiotherapy is the standard treatment for many patients with early-stage disease who have had their breasts removed and been put on anti-cancer drugs.

New prostate cancer research from an international team led by the Center for Genetic Epidemiology at the Keck School of Medicine of USC has yielded discoveries that could improve screening and treatment for patients of African ancestry.

New prostate cancer research from an international team led by the Center for Genetic Epidemiology at the Keck School of Medicine of USC has yielded discoveries that could improve screening and treatment for patients of African ancestry.

The 45-year-old mother of two says the hardest aspect of her vulvar cancer diagnosis has been coming to terms with leaving behind her eight-year-old twins.

NOVEMBER 5 — The horror stories of would-be cancer patients being gaslit by medical professionals are all too comm...

BURLINGTON, Mass., Nov. 4, 2025 /PRNewswire/ -- Azenta, Inc. (NASDAQ:AZTA) today announced a strategic partnership with the PRECEDE Foundation, an international, multi-institutional collaborative focused on early detection and prevention…

A European study has demonstrated a sustained long-term reduction in prostate cancer mortality through prostate-specific antigen (PSA) screening. However, the findings also highlight the issue of overdiagnosis, or the detection of slow…

A nurse who used a dirty needle on a teenage cancer patient and told them not to 'tell anyone' has been jailed for 15 months.

Glioblastoma is one of the most aggressive and complex brain cancers. It grows quickly, resists standard treatments, and often leaves patients and their families searching for every possible option.

New data provide key mechanistic insights into how TG4050 induces and sustains potent, CD8+ T cell responses in operable HNSCC[*] patients

WALTHAM, Mass., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Crescent Biopharma, Inc. ("Crescent" or the "Company") (NASDAQ:CBIO), a biotechnology company dedicated to rapidly advancing the next wave of therapies for cancer patients, today announced…

WALTHAM, Mass., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Crescent Biopharma, Inc. ("Crescent" or the "Company") (NASDAQ:CBIO), a biotechnology company dedicated to rapidly advancing the next wave of therapies for cancer patients, today announced…

Jordie Poncy was about to start his dream job as a psychologist at the Moffitt Cancer Center. Then he entered Moffitt as a patient himself.

The FDA-approved drug Pluvicto offers hope for advanced prostate cancer patients, but access barriers remain despite proven effectiveness in extending survival.